Header Logo

Connection

BING Z CARTER to Histone Deacetylase Inhibitors

Back to Details
This is a "connection" page, showing publications BING Z CARTER has written about Histone Deacetylase Inhibitors.
BING Z CARTER
Connection Strength
0.132
Histone Deacetylase Inhibitors
  1. A novel HDAC inhibitor chidamide combined with imatinib synergistically targets tyrosine kinase inhibitor resistant chronic myeloid leukemia cells. Biomed Pharmacother. 2020 Sep; 129:110390.
    View in: PubMed
    Score: 0.132
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.